반려동물 진단 서비스 시장 분석 및 예측 : 유형, 제품, 서비스, 기술, 컴포넌트, 용도, 최종 사용자, 기기, 솔루션, 모드(-2035년)

The global Companion Animal Diagnostic Services Market is projected to grow from $4.2 billion in 2025 to $7.5 billion by 2035, at a compound annual growth rate (CAGR) of 5.7%. The Companion Animal Diagnostic Services Market is characterized by a moderately consolidated structure, with the top segments being clinical biochemistry at approximately 35% market share, followed by immunodiagnostics at 30%, and molecular diagnostics at 20%. Key applications include disease screening, genetic testing, and wellness monitoring. The market is seeing a steady increase in diagnostic test volumes, driven by rising pet ownership and the humanization of pets.

In the Companion Animal Diagnostic Services Market, the 'Type' segment is crucial as it categorizes services into clinical biochemistry, immunodiagnostics, hematology, and molecular diagnostics. Immunodiagnostics dominates due to its broad application in detecting infectious diseases and monitoring immune responses. The demand is driven by the increasing pet ownership and the rising awareness of pet health. Notably, molecular diagnostics is gaining traction with advancements in genetic testing, offering precise diagnostics and personalized treatment plans.

The 'Technology' segment encompasses various diagnostic methodologies, with ELISA and PCR technologies leading due to their accuracy and reliability in detecting pathogens and genetic disorders. These technologies are pivotal in veterinary clinics and research institutions, where rapid and precise diagnostics are essential. The growth trend in this segment is fueled by technological advancements and the integration of AI and machine learning, which enhance diagnostic capabilities and streamline workflows.

Geographical Overview

North America dominates the companion animal diagnostic services market due to its high pet ownership rates and strong culture of pet humanization, where animals are treated as family members. This drives significant spending on advanced veterinary care, including diagnostic services. The region benefits from a well-developed network of veterinary clinics, diagnostic laboratories, and specialized service providers, ensuring easy access to testing services. In addition, widespread adoption of pet insurance and advanced technologies such as point-of-care diagnostics and imaging systems further accelerates demand, reinforcing the region's leading position.

Asia Pacific is the fastest-growing region in the companion animal diagnostic services market, driven by rising pet adoption and increasing awareness of animal health. Rapid urbanization and improving disposable incomes are encouraging higher spending on veterinary care across countries such as India and China. The region is also witnessing expansion in veterinary infrastructure and diagnostic capabilities, supported by growing investments and entry of global service providers. Additionally, the shift toward preventive healthcare and early disease detection in pets is boosting demand for diagnostic services, positioning Asia Pacific as a key growth hub.

Key Trends and Drivers

Rising Pet Humanization and Demand for Advanced Diagnostics:

The growing trend of pet humanization, where pets are treated as family members, is a key driver for the companion animal diagnostic services market. Pet owners are increasingly willing to spend on advanced healthcare services, including diagnostic testing, to ensure early disease detection and better treatment outcomes. Rising pet ownership, increasing veterinary visits, and expanding pet insurance coverage are further supporting this trend. Additionally, advancements in diagnostic technologies such as point-of-care testing, molecular diagnostics, and AI-based tools are enhancing accuracy and speed, encouraging widespread adoption of diagnostic services across veterinary clinics.

Expansion of Point-of-Care and At-Home Diagnostic Solutions:

The growing adoption of point-of-care and at-home diagnostic solutions presents significant opportunities in the market. These technologies enable rapid, real-time results, allowing veterinarians to make immediate clinical decisions and improve treatment outcomes. Increasing demand for convenient and stress-free testing solutions is also encouraging the development of portable and user-friendly diagnostic devices. Additionally, advancements in tele-veterinary services and digital health platforms are supporting remote monitoring and diagnostics. Expanding veterinary infrastructure in emerging markets and increasing investments in innovative diagnostic tools are further creating strong growth opportunities for market players globally.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Mode
• 2.8 Key Market Highlights by Equipment
• 2.9 Key Market Highlights by Solutions
• 2.10 Key Market Highlights by Component

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Clinical Chemistry
  • 4.1.2 Hematology
  • 4.1.3 Immunodiagnostics
  • 4.1.4 Molecular Diagnostics
  • 4.1.5 Urinalysis
  • 4.1.6 Microbiology
  • 4.1.7 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Instruments
  • 4.2.2 Consumables
  • 4.2.3 Reagents
  • 4.2.4 Kits
  • 4.2.5 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Diagnostic Imaging
  • 4.3.2 Laboratory Testing
  • 4.3.3 Consultation Services
  • 4.3.4 Telemedicine
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 PCR
  • 4.4.2 ELISA
  • 4.4.3 Lateral Flow Assays
  • 4.4.4 Flow Cytometry
  • 4.4.5 Biosensors
  • 4.4.6 Others
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Infectious Diseases
  • 4.5.2 Chronic Diseases
  • 4.5.3 Genetic Disorders
  • 4.5.4 Wellness Testing
  • 4.5.5 Oncology
  • 4.5.6 Others
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Veterinary Clinics
  • 4.6.2 Veterinary Hospitals
  • 4.6.3 Research Institutes
  • 4.6.4 Diagnostic Laboratories
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Mode (2020-2035)
  • 4.7.1 Point-of-Care Testing
  • 4.7.2 In-House Testing
  • 4.7.3 Reference Laboratory Testing
  • 4.7.4 Others
• 4.8 Market Size & Forecast by Equipment (2020-2035)
  • 4.8.1 X-ray Machines
  • 4.8.2 Ultrasound Systems
  • 4.8.3 MRI Scanners
  • 4.8.4 CT Scanners
  • 4.8.5 Others
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Data Management
  • 4.9.2 Workflow Automation
  • 4.9.3 Diagnostic Software
  • 4.9.4 Others
• 4.10 Market Size & Forecast by Component (2020-2035)
  • 4.10.1 Hardware
  • 4.10.2 Software
  • 4.10.3 Services
  • 4.10.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 End User
    • 5.2.1.7 Mode
    • 5.2.1.8 Equipment
    • 5.2.1.9 Solutions
    • 5.2.1.10 Component
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 End User
    • 5.2.2.7 Mode
    • 5.2.2.8 Equipment
    • 5.2.2.9 Solutions
    • 5.2.2.10 Component
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 End User
    • 5.2.3.7 Mode
    • 5.2.3.8 Equipment
    • 5.2.3.9 Solutions
    • 5.2.3.10 Component
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 End User
    • 5.3.1.7 Mode
    • 5.3.1.8 Equipment
    • 5.3.1.9 Solutions
    • 5.3.1.10 Component
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 End User
    • 5.3.2.7 Mode
    • 5.3.2.8 Equipment
    • 5.3.2.9 Solutions
    • 5.3.2.10 Component
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 End User
    • 5.3.3.7 Mode
    • 5.3.3.8 Equipment
    • 5.3.3.9 Solutions
    • 5.3.3.10 Component
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 End User
    • 5.4.1.7 Mode
    • 5.4.1.8 Equipment
    • 5.4.1.9 Solutions
    • 5.4.1.10 Component
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 End User
    • 5.4.2.7 Mode
    • 5.4.2.8 Equipment
    • 5.4.2.9 Solutions
    • 5.4.2.10 Component
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 End User
    • 5.4.3.7 Mode
    • 5.4.3.8 Equipment
    • 5.4.3.9 Solutions
    • 5.4.3.10 Component
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 End User
    • 5.4.4.7 Mode
    • 5.4.4.8 Equipment
    • 5.4.4.9 Solutions
    • 5.4.4.10 Component
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 End User
    • 5.4.5.7 Mode
    • 5.4.5.8 Equipment
    • 5.4.5.9 Solutions
    • 5.4.5.10 Component
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 End User
    • 5.4.6.7 Mode
    • 5.4.6.8 Equipment
    • 5.4.6.9 Solutions
    • 5.4.6.10 Component
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 End User
    • 5.4.7.7 Mode
    • 5.4.7.8 Equipment
    • 5.4.7.9 Solutions
    • 5.4.7.10 Component
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 End User
    • 5.5.1.7 Mode
    • 5.5.1.8 Equipment
    • 5.5.1.9 Solutions
    • 5.5.1.10 Component
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 End User
    • 5.5.2.7 Mode
    • 5.5.2.8 Equipment
    • 5.5.2.9 Solutions
    • 5.5.2.10 Component
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 End User
    • 5.5.3.7 Mode
    • 5.5.3.8 Equipment
    • 5.5.3.9 Solutions
    • 5.5.3.10 Component
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 End User
    • 5.5.4.7 Mode
    • 5.5.4.8 Equipment
    • 5.5.4.9 Solutions
    • 5.5.4.10 Component
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 End User
    • 5.5.5.7 Mode
    • 5.5.5.8 Equipment
    • 5.5.5.9 Solutions
    • 5.5.5.10 Component
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 End User
    • 5.5.6.7 Mode
    • 5.5.6.8 Equipment
    • 5.5.6.9 Solutions
    • 5.5.6.10 Component
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 End User
    • 5.6.1.7 Mode
    • 5.6.1.8 Equipment
    • 5.6.1.9 Solutions
    • 5.6.1.10 Component
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 End User
    • 5.6.2.7 Mode
    • 5.6.2.8 Equipment
    • 5.6.2.9 Solutions
    • 5.6.2.10 Component
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 End User
    • 5.6.3.7 Mode
    • 5.6.3.8 Equipment
    • 5.6.3.9 Solutions
    • 5.6.3.10 Component
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 End User
    • 5.6.4.7 Mode
    • 5.6.4.8 Equipment
    • 5.6.4.9 Solutions
    • 5.6.4.10 Component
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 End User
    • 5.6.5.7 Mode
    • 5.6.5.8 Equipment
    • 5.6.5.9 Solutions
    • 5.6.5.10 Component

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 IDEXX Laboratories
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Zoetis
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Thermo Fisher Scientific
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Heska Corporation
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Neogen Corporation
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Virbac
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Bio-Rad Laboratories
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Randox Laboratories
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Abaxis
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 VCA Antech
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Agrolabo
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Eurofins Scientific
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Qiagen
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Biomerieux
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Mindray
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Scil Animal Care
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 IDvet
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Biogal Galed Labs
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Woodley Equipment Company
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Skyla
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us